VOYA Investment Management
AVIR icon

VOYA Investment Management’s Atea Pharmaceuticals AVIR Stock Holding History

VOYA Investment Management’s Portfolio AVIR Stock Details AVIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$75.5K Buy
16,242
+1,985
+14% +$9.87K ﹤0.01% 2390
2026
Q1 		$76.7K Sell
14,257
-2,192
-13% -$10.1K ﹤0.01% 2228
2025
Q4 		$58.7K Hold
16,449
– – ﹤0.01% 2325
2025
Q3 		$47.7K Sell
16,449
-8,648
-34% -$29.5K ﹤0.01% 2388
2025
Q2 		$90.3K Hold
25,097
– – ﹤0.01% 2510
2025
Q1 		$75K Sell
25,097
-4,245
-14% -$13.3K ﹤0.01% 2482
2024
Q4 		$98.3K Sell
29,342
-1,632
-5% -$5.42K ﹤0.01% 2580
2024
Q3 		$104K Sell
30,974
-339
-1% -$1.23K ﹤0.01% 2655
2024
Q2 		$104K Buy
31,313
+2,766
+10% +$10.3K ﹤0.01% 2658
2024
Q1 		$115K Sell
28,547
-4,739
-14% -$18.5K ﹤0.01% 2601
2023
Q4 		$102K Hold
33,286
– – ﹤0.01% 2753
2023
Q3 		$99.9K Sell
33,286
-29,552
-47% -$101K ﹤0.01% 2733
2023
Q2 		$235K Buy
62,838
+961
+2% +$3.6K ﹤0.01% 2504
2023
Q1 		$207K Buy
61,877
+7,093
+13% +$28.8K ﹤0.01% 2516
2022
Q4 		$264K Buy
54,784
+24,327
+80% +$123K ﹤0.01% 2418
2022
Q3 		$173K Buy
30,457
+2,072
+7% +$15.9K ﹤0.01% 2646
2022
Q2 		$202K Buy
28,385
+3,636
+15% +$24.8K ﹤0.01% 2390
2022
Q1 		$179K Hold
24,749
– – ﹤0.01% 2394
2021
Q4 		$221K Sell
24,749
-725
-3% -$11.3K ﹤0.01% 2452
2021
Q3 		$893K Hold
25,474
– – ﹤0.01% 1647
2021
Q2 		$547K Buy
25,474
+19,120
+301% +$574K ﹤0.01% 2030
2021
Q1 		$392K Buy
6,354
+1,526
+32% +$103K ﹤0.01% 2162
2020
Q4 		$202K Buy
+4,828
New +$156K ﹤0.01% 2418

Other funds holding AVIR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $176M AUM 123.21% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

VOYA Investment Management's AVIR Position: Q2 2026 in Review

VOYA Investment Management increased its Atea Pharmaceuticals (AVIR) stake by 14% in Q2 2026, buying an estimated $9.87K and bringing the position to 16,242 shares worth $75.5K. The position accounts for ﹤0.01% of the portfolio, ranked #2390.

VOYA Investment Management first reported a position in AVIR in Q4 2020 and has held it in 23 quarters since. The position peaked at $893K in Q3 2021. 124 funds tracked by Wall St. Rank hold AVIR as of Q2 2026.

  • VOYA Investment Management held 16,242 shares of Atea Pharmaceuticals worth $75.5K as of Q2 2026.
  • VOYA Investment Management bought 1,985 Atea Pharmaceuticals shares in Q2 2026, an estimated $9.87K.
  • Atea Pharmaceuticals made up ﹤0.01% of VOYA Investment Management's portfolio in Q2 2026, its #2390 holding.
  • VOYA Investment Management first reported a position in Atea Pharmaceuticals in Q4 2020 and has held it in 23 quarters since.
  • VOYA Investment Management's Atea Pharmaceuticals position peaked at $893K in Q3 2021.
  • 124 funds tracked by Wall St. Rank held Atea Pharmaceuticals as of Q2 2026.

Based on VOYA Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.